What the FDA labels say about taking them together
Darifenacin and thioridazine
Darifenacin's FDA label of February 10, 2026 names thioridazine in its drug interactions section; the thioridazine label PlainMeds reads does not name darifenacin. The darifenacin label: “… by CYP2D6 and which have a narrow therapeutic window, such as flecainide, thioridazine and tricyclic antidepressants The concomitant use of darifenacin extended-release tablets with other anticholinergic agents may …”
Check it at the source: the darifenacin FDA label on DailyMed (effective February 10, 2026, Torrent Pharmaceuticals Limited); the thioridazine FDA label on DailyMed (effective November 11, 2025, Mylan Institutional Inc.).
What does the darifenacin label say about thioridazine?
Darifenacin label, drug interactionsDRUG INTERACTIONS Caution should be taken when darifenacin extended-release tablets is used concomitantly with medications that are predominantly metabolized by CYP2D6 and which have a narrow therapeutic window, such as flecainide, thioridazine and tricyclic antidepressants ( 7.2 ) The concomitant use of darifenacin extended-release tablets with other anticholinergic agents may increase the frequency and/or severity of dry mouth, constipation, blurred vision and other anticholinergic pharmacological effects.
Source: FDA drug label (Darifenacin), Torrent Pharmaceuticals Limited, effective February 10, 2026 (SPL set e84f1ae3-b9a2-4a15-a299-c75373891cc1), via openFDA; the full label on DailyMed
What does the thioridazine label say about darifenacin?
Thioridazine's label (effective November 11, 2025) does not name darifenacin in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Thioridazine Hydrochloride), Mylan Institutional Inc., effective November 11, 2025 (SPL set 52fea941-0b47-41c1-b00d-f88150e8ab93), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Darifenacin | Thioridazine | |
|---|---|---|
| Labeled for | Overactive bladder | n/a |
| Boxed warning | No | Yes |
| Pharmacy cost (NADAC) | $0.432 per tablet 15 mg tablet | $0.571 per tablet 25 mg tablet |
| Shortage now | No current entry | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once